MEI Pharma, Inc. (MEIP)

MEI Pharma Statistics

Total Valuation

MEI Pharma has a market cap or net worth of $159.08 million. The enterprise value is $140.07 million.

Market Cap	159.08M
Enterprise Value	140.07M

Important Dates

The next estimated earnings date is Thursday, September 18, 2025, after market close.

Earnings Date	Sep 18, 2025
Ex-Dividend Date	n/a

Share Statistics

MEI Pharma has 32.37 million shares outstanding.

Current Share Class	32.37M
Shares Outstanding	32.37M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.79%
Owned by Institutions (%)	8.52%
Float	30.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.75
P/TBV Ratio	8.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.78

Current Ratio	16.78
Quick Ratio	16.54
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -89.74% and return on invested capital (ROIC) is -25.99%.

Return on Equity (ROE)	-89.74%
Return on Assets (ROA)	-23.23%
Return on Invested Capital (ROIC)	-25.99%
Return on Capital Employed (ROCE)	-87.52%
Revenue Per Employee	n/a
Profits Per Employee	-$1.13M
Employee Count	28
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +45.88% in the last 52 weeks. The beta is 0.21, so MEI Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.21
52-Week Price Change	+45.88%
50-Day Moving Average	3.74
200-Day Moving Average	2.81
Relative Strength Index (RSI)	53.64
Average Volume (20 Days)	3,224,215

Short Selling Information

The latest short interest is 2.15 million, so 6.63% of the outstanding shares have been sold short.

Short Interest	2.15M
Short Previous Month	17,652
Short % of Shares Out	6.63%
Short % of Float	7.12%
Short Ratio (days to cover)	0.82

Income Statement

Revenue	n/a
Gross Profit	-5.59M
Operating Income	-17.10M
Pretax Income	26.16M
Net Income	-31.66M
EBITDA	-16.61M
EBIT	-17.10M
Earnings Per Share (EPS)	-$4.75

Balance Sheet

The company has $20.47 million in cash and n/a in debt, giving a net cash position of $20.47 million or $0.63 per share.

Cash & Cash Equivalents	20.47M
Total Debt	n/a
Net Cash	20.47M
Net Cash Per Share	$0.63
Equity (Book Value)	19.54M
Book Value Per Share	2.93
Working Capital	19.54M

Cash Flow

Operating Cash Flow	-36.38M
Capital Expenditures	n/a
Free Cash Flow	-36.38M
FCF Per Share	-$1.12

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MEI Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-19.72%
FCF Yield	-22.66%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 17, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Apr 17, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

MEI Pharma has an Altman Z-Score of -19.22 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-19.22
Piotroski F-Score	1